These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9758203)

  • 1. Effective long-term inhibition of thromboxane production but not of serotonin release in patients with coronary heart disease by 30 mg/d acetylsalicylic acid dosage.
    Gajdos M; Spustová V; Sebeková K; Krivosiková Z; Dzúrik R
    Prostaglandins Leukot Essent Fatty Acids; 1998 Jul; 59(1):17-21. PubMed ID: 9758203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One milligramme of acetylsalicylic acid daily inhibits platelet thromboxane A2 production.
    Toivanen J; Ylikorkala O; Viinikka L
    Thromb Res; 1984 Sep; 35(6):681-7. PubMed ID: 6506023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM; Böger RH; Schubert M; Frölich JC
    Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
    Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
    Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the urine and plasma determinants of thromboxane A2 metabolism in detection of aspirin effectiveness.
    Dobaczewski M; Nocun M; Zavodnik I; Ulicna O; Lapshina E; Zavodnik L; Golanski J; Kazmierczak P; Durackova Z; Kostka B; Markuszewski L; Watala C
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):421-8. PubMed ID: 18600093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the platelet P2Y12 receptor for adenosine diphosphate does not impair the capacity of platelet to synthesize thromboxane A2.
    Scavone M; Femia EA; Caroppo V; Cattaneo M
    Eur Heart J; 2016 Nov; 37(44):3347-3356. PubMed ID: 26516174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro.
    Toivanen J; Ylikorkala O; Viinikka L
    Thromb Res; 1985 Feb; 37(4):493-502. PubMed ID: 3920778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In the dose range of 0.5-2.0 mg/kg, acetylsalicylic acid does not affect prostacyclin production in hypertensive pregnancies.
    Vainio M; Mäenpää J; Riutta A; Ylitalo P; Ala-Fossi SL; Tuimala R
    Acta Obstet Gynecol Scand; 1999 Feb; 78(2):82-8. PubMed ID: 10023867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acetylsalicylic acid on plasma thromboxane B2 and platelet aggregation in man.
    Nuotto E; Gordin A; Paasonen MK; Metsä-Ketelä T; Lamminsivu U
    Eur J Clin Pharmacol; 1983; 25(3):313-7. PubMed ID: 6628518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
    DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
    Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical cord serum levels of thromboxane B2 in term infants of women who participated in a placebo-controlled trial of low-dose aspirin.
    Parker CR; Hauth JC; Goldenberg RL; Cooper RL; Dubard MB
    J Matern Fetal Med; 2000; 9(4):209-15. PubMed ID: 11048830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.
    Patrick J; Dillaha L; Armas D; Sessa WC
    Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation.
    Petrucci G; Giaretta A; Ranalli P; Cavalca V; Dragani A; Porro B; Hatem D; Habib A; Tremoli E; Patrono C; Rocca B
    Clin Transl Sci; 2022 Dec; 15(12):2958-2970. PubMed ID: 36200184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose acetylsalicylic acid and thromboxane release at the site of plug formation in vivo in elderly patients with cardiovascular disease.
    Thorngren M; Eckert B; Vinge E
    J Intern Med; 1990 Mar; 227(3):189-93. PubMed ID: 2313226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study.
    Kaplon-Cieslicka A; Postula M; Rosiak M; Peller M; Kondracka A; Serafin A; Trzepla E; Opolski G; Filipiak KJ
    Cardiovasc Diabetol; 2014 Aug; 13():112. PubMed ID: 25123549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
    Lorenz R; Siess W; Weber PC
    Eur J Pharmacol; 1981 Apr; 70(4):511-8. PubMed ID: 7238575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of low dose aspirin on platelet function and prostaglandins metabolism in systemic and coronary circulation in patients with ischemia heart disease].
    Liu H; Chen Z; Gao R
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):595-8. PubMed ID: 8697924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey.
    Patrignani P; Morton H; Cirino M; Lord A; Charette L; Gillard J; Rokach J; Patrono C
    Biochim Biophys Acta; 1989 Jul; 992(1):71-7. PubMed ID: 2752041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early assessment of the pharmacokinetic and pharmacodynamic effects following acetylsalicylic acid loading: toward a definition for acute therapeutic response.
    Gurbel PA; Bliden KP; Kundan P; Kraft D; Parekh R; Singh S; Babu AD; Shah AP; Chaudhary R; Tantry US
    J Thromb Thrombolysis; 2024 Jan; 57(1):21-28. PubMed ID: 38066385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.